- Home
- GP vs AIDX Comparison
GP vs AIDX Comparison
Compare GP & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GP | AIDX |
|---|---|---|
| Founded | 2010 | N/A |
| Country | Canada | United States |
| Employees | N/A | 14 |
| Industry | Construction/Ag Equipment/Trucks | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7M | 7.2M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | GP | AIDX |
|---|---|---|
| Price | $1.44 | $0.55 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 248.4K | ★ 458.8K |
| Earning Date | 02-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.23 | $0.51 |
| 52 Week High | $4.00 | $14.09 |
Technical Indicators
Market Signals| Indicator | GP | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 56.64 | 34.10 |
| Support Level | $0.86 | $0.52 |
| Resistance Level | $1.46 | $0.70 |
| Average True Range (ATR) | 0.14 | 0.06 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 47.13 | 24.35 |
Price Performance
Historical ComparisonAbout GP GreenPower Motor Company Inc.
GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.